A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis ; volume:22 ; number:1 ; day:24 ; month:6 ; year:2020 ; pages:1-12 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (24.6.2020), 1-12, 12.2020
- Urheber
-
Ma, M. H. Y.
Defranoux, N.
Li, W.
Sasso, E. H.
Ibrahim, F.
Scott, D. L.
Cope, A. P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02240-w
- URN
-
urn:nbn:de:101:1-2020082021154766980021
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ma, M. H. Y.
- Defranoux, N.
- Li, W.
- Sasso, E. H.
- Ibrahim, F.
- Scott, D. L.
- Cope, A. P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature
Impact of sustained remission on quality of life among women with rheumatoid arthritis and systemic lupus erythematosus: a prospective observational study
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature
Impact of sustained remission on quality of life among women with rheumatoid arthritis and systemic lupus erythematosus: a prospective observational study
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis
Sustained rheumatoid arthritis remission is uncommon in clinical practice
Patient’s perspective of sustained remission in rheumatoid arthritis
Defining and characterizing sustained remission in patients with rheumatoid arthritis
Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: a case report and review of the literature
Impact of sustained remission on quality of life among women with rheumatoid arthritis and systemic lupus erythematosus: a prospective observational study
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients